Synthomer Beheer
Beheer criteriumcontroles 1/4
De CEO Synthomer is Michael Willome, benoemd in Nov2021, heeft een ambtstermijn van 4.5 jaar. De totale jaarlijkse vergoeding van { bedraagt £ 1.55M, bestaande uit 45.2% salaris en 54.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.4% van de aandelen van het bedrijf, ter waarde £ 636.03K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 2.7 jaar.
Belangrijke informatie
Michael Willome
Algemeen directeur
UK£1.6m
Totale compensatie
| Percentage CEO-salaris | 45.23% |
| Dienstverband CEO | 4.5yrs |
| Eigendom CEO | 0.4% |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 2.7yrs |
Recente managementupdates
Recent updates
SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Stability
Analysts have slightly reduced their price expectations for Synthomer, reflecting updated assumptions for a less pronounced revenue decline, a small reduction in forecast profit margins, and a modest adjustment to future P/E. Taken together, these changes leave their fair value estimate unchanged at £0.59 per share.
SYNT: Cost Cuts And Bio Based Shift Will Support Future Upside
Analysts have nudged their price target on Synthomer slightly, reflecting modest tweaks to assumptions around discount rate, profit margin and future P/E, while keeping the underlying fair value estimate broadly unchanged at £1.27. What's in the News Godavari Biorefineries Limited entered a partnership with Synthomer to develop bio-based alternatives to existing fossil-based monomers, targeting growing customer demand for lower carbon and more sustainable materials (Key Developments).SYNT: Cost Actions And Bio-Based Partnership Will Support Future Margin Resilience
Analysts have adjusted their Synthomer price targets slightly to reflect updated views on revenue contraction, slightly higher profit margins, and a modestly lower future P/E, resulting in a revised fair value estimate of £0.59 per share. What's in the News Synthomer entered a partnership with Godavari Biorefineries Limited to develop bio-based alternatives to existing fossil-based monomers.SYNT: Cost Actions And Bio Based Shift Will Support Earnings Recovery
Analysts have trimmed their price target on Synthomer from £1.34 to about £1.27, citing updated assumptions on revenue growth, profit margins and future P/E multiples as they reassess the balance of risk and reward. What's in the News Godavari Biorefineries Limited partnered with Synthomer to develop bio-based alternatives to existing fossil-based monomers, including commercialisation of bio-based butyl acrylate using bio-based butanol from GBL, aimed at supporting customer demand for lower carbon materials (Key Developments).SYNT: Cost Actions And Bio-Based Shift Will Support Future Margin Resilience
Analysts have nudged their price target on Synthomer higher to £0.59. This reflects updated assumptions around slightly less severe revenue contraction and broadly unchanged profit margins and P/E expectations.SYNT: Cost Actions And Margin Resilience Will Support A Stable Fair Value View
Analysts have nudged their fair value estimate for Synthomer to £0.59 from £0.55, citing revised assumptions around revenue growth, profit margins and future P/E as the key drivers of the updated price target. What's in the News Synthomer issued earnings guidance for the twelve months to 31 December 2025, with expected 2025 revenue of around £1.74b compared with £1.93b for 2024, described as in line with market expectations (Key Developments).SYNT: Earnings Prospects Will Stabilise As Fair Value View Remains Intact
Analysts have adjusted their price targets on Synthomer, reflecting revised assumptions around revenue growth, profit margins and future P/E multiples. Together, these changes point to a recalibrated view of the company’s earnings potential within an unchanged fair value estimate of £0.55 per share.SYNT: Self Help And 2026 Outlook Will Support Earnings Recovery
Analysts have trimmed their price expectations for Synthomer, with a lower fair value estimate and a reduced Street target to £1.02 from £1.12. This reflects updated views on revenue growth and earnings multiples while maintaining a broadly neutral stance on the shares.SYNT Will Face Mounting Pressure As Earnings Recovery Outlook Deteriorates
The analyst price target for Synthomer has been reduced to £1.02 per share from £1.12, as analysts factor in slower revenue growth assumptions, despite slightly higher profit margin expectations and a marginally increased discount rate. Analyst Commentary Recent research updates highlight a cautious stance from bearish analysts, who have progressively lowered their price targets on Synthomer as they reassess the company’s growth trajectory and risk profile.SYNT: Self-Help Actions Will Drive Earnings Recovery Despite Neutral Market Sentiment
Analysts have trimmed their price target on Synthomer slightly. This reflects a modest recalibration in fair value to approximately £1.34 per share following a series of recent target cuts that have reset expectations for the stock.SYNT: Full-Year Self-Help Actions Will Drive Earnings Recovery Momentum
Analysts have revised their price target for Synthomer downward from GBp 112 to GBp 102. This change is attributed to adjustments to future valuation metrics and an updated earnings outlook.SYNT: Future Gains Are Expected As End Markets Gradually Stabilize
Synthomer's analyst price target has been reduced from 112 GBp to 102 GBp. Analysts cite persistent end-market challenges and limited near-term prospects for earnings recovery as key factors behind the downward revision. Analyst Commentary Recent analyst coverage reflects a spectrum of perspectives regarding Synthomer's outlook, shaped by evolving market dynamics and the company's updated financial guidance.Future Earnings And Recovery Prospects Will Remain Under Pressure Amid Market Challenges
Synthomer's fair value estimate has been revised downward from £1.54 to £1.38 per share. Analysts cite ongoing challenges in end markets and modest growth prospects following the company's recent interim results.UK£1.57: That's What Analysts Think Synthomer plc (LON:SYNT) Is Worth After Its Latest Results
Aug 09
Sustainable Specialty Polymers Will Unlock New Global Opportunities
Despite a notable upgrade in revenue growth forecasts and a reduction in the forward P/E, Synthomer's consensus analyst price target has been revised down from £1.71 to £1.57. Valuation Changes Summary of Valuation Changes for Synthomer The Consensus Analyst Price Target has fallen from £1.71 to £1.57.
Chemical Realignment And Adhesives Expansion Will Build A Resilient Future
Shift to high-margin specialty chemicals and divestment of non-core operations are expected to enhance profitability.Investors Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues
Jan 08Synthomer plc (LON:SYNT) Screens Well But There Might Be A Catch
Oct 05Calculating The Intrinsic Value Of Synthomer plc (LON:SYNT)
Aug 03Synthomer (LON:SYNT) Has Debt But No Earnings; Should You Worry?
Jun 18Investors Still Aren't Entirely Convinced By Synthomer plc's (LON:SYNT) Revenues Despite 27% Price Jump
May 25Is Synthomer plc (LON:SYNT) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 20Even With A 45% Surge, Cautious Investors Are Not Rewarding Synthomer plc's (LON:SYNT) Performance Completely
Mar 14Should You Think About Buying Synthomer plc (LON:SYNT) Now?
Feb 08Is Now An Opportune Moment To Examine Synthomer plc (LON:SYNT)?
Oct 17Here's Why Synthomer (LON:SYNT) Is Weighed Down By Its Debt Load
Sep 12Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Dec 31 2025 | n/a | n/a | -UK£150m |
| Sep 30 2025 | n/a | n/a | -UK£113m |
| Jun 30 2025 | n/a | n/a | -UK£76m |
| Mar 31 2025 | n/a | n/a | -UK£73m |
| Dec 31 2024 | UK£2m | UK£702k | -UK£70m |
| Sep 30 2024 | n/a | n/a | -UK£78m |
| Jun 30 2024 | n/a | n/a | -UK£86m |
| Mar 31 2024 | n/a | n/a | -UK£96m |
| Dec 31 2023 | UK£1m | UK£675k | -UK£105m |
| Sep 30 2023 | n/a | n/a | -UK£127m |
| Jun 30 2023 | n/a | n/a | -UK£149m |
| Mar 31 2023 | n/a | n/a | -UK£84m |
| Dec 31 2022 | UK£987k | UK£650k | -UK£18m |
| Jun 30 2022 | n/a | n/a | UK£80m |
| Mar 31 2022 | n/a | n/a | UK£139m |
| Dec 31 2021 | UK£789k | UK£108k | UK£198m |
Compensatie versus markt: De totale vergoeding ($USD 2.11M ) Michael } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de UK markt ($USD 827.86K ).
Compensatie versus inkomsten: De vergoeding van Michael is gestegen terwijl het bedrijf verliesgevend is.
CEO
Michael Willome (59 yo)
Mr. Michael Willome, lic. oec. HSG serves as the Chief Executive Officer at Synthomer plc since November 1, 2021 and serves as its Executive Director since November 2021.He had been Group Chief Executive...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Executive Director | 4.5yrs | UK£1.55m | 0.40% £ 636.0k | |
| CFO & Director | 3.8yrs | UK£1.14m | 0.094% £ 148.3k | |
| Vice President of Investor Relations | 3.3yrs | geen gegevens | geen gegevens | |
| Interim Chief Human Resources Officer | 3.4yrs | geen gegevens | geen gegevens | |
| President of Health | 7.7yrs | geen gegevens | geen gegevens | |
| President of Coatings & Construction Solutions and EMEA | 4.3yrs | geen gegevens | geen gegevens | |
| President of Strategy and M&A | 3.7yrs | geen gegevens | geen gegevens | |
| President of Adhesive Solutions | 3yrs | geen gegevens | geen gegevens |
Ervaren management: Het managementteam van SYNT wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO & Executive Director | 4.5yrs | UK£1.55m | 0.40% £ 636.0k | |
| CFO & Director | 3.8yrs | UK£1.14m | 0.094% £ 148.3k | |
| Non-Executive Director | 23.7yrs | UK£46.60k | 0.10% £ 158.7k | |
| Independent Non-Executive Director | less than a year | geen gegevens | 0.036% £ 57.4k | |
| Independent Non-Executive Chairman | 1.7yrs | UK£20.53k | 0.031% £ 48.5k | |
| Independent Non-Executive Director | 2.7yrs | UK£61.60k | geen gegevens | |
| Independent Non-Executive Director | 7.7yrs | UK£71.60k | 0.015% £ 23.3k | |
| Non-Executive Director | 1.7yrs | UK£15.53k | 0.015% £ 24.2k | |
| Senior Independent Director | less than a year | geen gegevens | 0.012% £ 19.3k |
Ervaren bestuur: De raad van bestuur van SYNT wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.7 jaar), wat duidt op een nieuw bestuur.
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/04 20:09 |
| Aandelenkoers aan het einde van de dag | 2026/05/01 00:00 |
| Inkomsten | 2025/12/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Synthomer plc wordt gevolgd door 21 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Katie Richards | Barclays |
| Robert Bate | Barclays |
| James Stewart | Barclays |